Trametinib M4 Metabolite | CAS 1620017-28-8 - Solicitar cotización

Trametinib M4 Metabolite is chemically (2S,3S,4S,5R)-6-(2-amino-4-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid. Trametinib M4 Metabolite is supplied with detailed characterization data compliant with regulatory guideline. Trametinib M4 Metabolite can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Trametinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.